Improving survival among Brazilian children with perinatally-acquired AIDS

Luiza Harunari Matida1, Luiz Francisco Marcopito, Regina Celia de Menezes Succi

  • 1São Paulo State STD/AIDS Program, and Federal University of São Paulo (UNIFESP), São Paulo-SP, Brazil.

Insights

Brazil

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Brazil pioneered free, universal antiretroviral treatment (ART) for AIDS patients, offering a unique model for developing nations.
  • The impact of ART on survival for perinatally acquired AIDS in the developing world was previously unestablished.

Purpose of the Study:

  • To evaluate the impact of universal antiretroviral treatment on the survival rates of children with perinatally acquired AIDS in Brazil.
  • To analyze trends in survival for pediatric AIDS cases within the Brazilian healthcare system.

Main Methods:

  • A retrospective cohort study.
  • Involved medical record reviews of 914 children with perinatally acquired AIDS.
  • Data collected from 10 Brazilian cities, with diagnoses spanning 1983 to 1998.

Main Results:

  • Significant and steady increases in survival time were observed.
  • Children diagnosed in 1997-1998 showed a 75% survival rate after four years, a substantial improvement from earlier diagnoses.
  • Earlier diagnosed children had a median survival of only 20 months.

Conclusions:

  • Advances in AIDS management and treatment significantly improved survival for Brazilian children.
  • The findings strongly support the expansion of universal antiretroviral treatment to children globally, particularly in developing countries.
Abstract